Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Isolation of Mammalian Mesoangioblasts: A Subset of Pericytes with Myogenic Potential.
Abstract: Mesoangioblasts (MABs) are vessel-associated stem cells that express pericyte markers and are originally isolated from the embryonic dorsal aorta. From postnatal small vessels of skeletal muscle and heart, it is possible to isolate cells with similar characteristics to embryonic MABs. Adult MABs have the capacity to self-renew and to differentiate into cell types of mesodermal lineages upon proper culture conditions. To date, the origin of MABs and the relationship with other muscle stem cells are still debated. Recently, in a phase I-II clinical trial, intra-arterial HLA-matched MABs were proved to be relatively safe. Novel information on MAB pure populations is desirable, and implementation of their therapeutic potential is mandatory to approach efficacy in MAB-based treatments. This chapter provides an overview of the current techniques for isolation and characterization of rodent, canine, human, and equine adult MABs.
Publication Date: 2021-02-13 PubMed ID: 33576976DOI: 10.1007/978-1-0716-1056-5_11Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article focuses on exploring the nature of mesoangioblasts (MABs), which are a type of stem cells associated with vessels. MABs possess the ability to self-renew and differentiate into other cell types within certain conditions, making them of particular interest for therapeutic applications.
Understanding Mesoangioblasts
Mesoangioblasts (MABs) are a type of stem cells that are connected with vessels and demonstrate pericyte markers. They were originally isolated from the embryonic dorsal aorta, but further studies have confirmed that cells with similar characteristics can also be isolated from the small vessels of skeletal muscle and heart of postnatal mammals. These adult MABs possess the capacity to self-replenish and differentiate into other cell types of mesodermal lineage, given the right culture conditions.
- This research is crucial because the origin of MABs and their relationship with other muscle stem cells are still topics of ongoing debate in the scientific community.
Therapeutic Potential of MABs
Studies have provided empirical evidence supporting the therapeutic potential of mesoangioblasts. A phase I-II clinical trial has proved that HLA (Human Leukocyte Antigen) matched MABs, delivered intra-arterially, are relatively safe.
- Due to their capacity for self-renewal and differentiation, MABs are viewed as promising candidates for a range of potential therapeutic applications, particularly for treating various muscle and heart conditions.
- However, additional facts on pure MAB populations are needed, and plans to implement their therapeutic potential must be developed with a view to ensuring efficacy in MAB-based treatments.
Current Techniques for Isolation and Characterization of MABs
This research article provides an overview of current methodologies for isolating and characterizing adult MABs from several species including rodents, canines, humans, and horses. These methods offer essential insights for researchers seeking to better understand MABs and their role in treatment.
- The examination and understanding of the complexity of these procedures and techniques are essential for further advancements in MAB research and their potential therapeutic uses.
Cite This Article
APA
(2021).
Isolation of Mammalian Mesoangioblasts: A Subset of Pericytes with Myogenic Potential.
Methods Mol Biol, 2235, 155-167.
https://doi.org/10.1007/978-1-0716-1056-5_11 Publication
Researcher Affiliations
MeSH Terms
- Animals
- Aorta / cytology
- Cell Differentiation / physiology
- Cell Separation / methods
- Dogs
- Horses
- Humans
- Mesoderm / cytology
- Mice
- Muscle Development
- Muscle, Skeletal / cytology
- Myoblasts / cytology
- Pericytes / cytology
- Pericytes / physiology
- Rats
- Stem Cells / cytology
References
This article includes 20 references
- Kuang S, Kuroda K, Le Grand F, Rudnicki MA. asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129(5):999–1010.
- Cossu G, Biressi S. Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin Cell Dev Biol 16(4-5):623–631.
- Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9(3):255–267.
- Dellavalle A, Maroli G, Covarello D, Azzoni E, Innocenzi A, Perani L. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun 2:499.
- Quattrocelli M, Costamagna D, Giacomazzi G, Camps J, Sampaolesi M. Notch signaling regulates myogenic regenerative capacity of murine and human mesoangioblasts. Cell Death Dis 5:e1448.
- Costamagna D, Quattrocelli M, van Tienen F, Umans L, de Coo IF, Zwijsen A. Smad1/5/8 are myogenic regulators of murine and human mesoangioblasts. J Mol Cell Biol 8(1):73–87.
- Bonfanti C, Rossi G, Tedesco FS, Giannotta M, Benedetti S, Tonlorenzi R. PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence. Nat Commun 6:6364.
- Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino MA. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301(5632):487–492.
- Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444(7119):574–579.
- Quattrocelli M, Swinnen M, Giacomazzi G, Camps J, Barthélemy I, Ceccarelli G. Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. J Clin Invest 125(12):4463–4482.
- Cossu G, Previtali SC, Napolitano S, Cicalese MP, Tedesco FS, Nicastro F. Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy. EMBO Mol Med 7(12):1513–1528.
- Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301–313.
- Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6):763–776.
- Galvez BG, Sampaolesi M, Barbuti A, Crespi A, Covarello D, Brunelli S. Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ 15(9):1417–1428.
- Galvez BG, Covarello D, Tolorenzi R, Brunelli S, Dellavalle A, Crippa S. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovasc Res 83(4):707–716.
- Costamagna D, Quattrocelli M, Duelen R, Sahakyan V, Perini I, Palazzolo G, Sampaolesi M. Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. Cell Mol Life Sci 71(4):615–627.
- Crippa S, Cassano M, Messina G, Galli D, Galvez BG, Curk T. miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol 193(7):1197–1212.
- Chen WC, Baily JE, Corselli M, Díaz ME, Sun B, Xiang G. Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity. Stem Cells 33(2):557–573.
- Quattrocelli M, Giacomazzi G, Broeckx SY, Ceelen L, Bolca S, Spaas JH, Sampaolesi M. Equine-induced pluripotent stem cells retain lineage commitment toward myogenic and Chondrogenic fates. Stem Cell Rep 6(1):55–63.
- Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M. Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol Chapter 2:Unit 2B.1.
Citations
This article has been cited 3 times.- Gatti M, Dittlau KS, Beretti F, Yedigaryan L, Zavatti M, Cortelli P, Palumbo C, Bertucci E, Van Den Bosch L, Sampaolesi M, Maraldi T. Human Neuromuscular Junction on a Chip: Impact of Amniotic Fluid Stem Cell Extracellular Vesicles on Muscle Atrophy and NMJ Integrity. Int J Mol Sci 2023 Mar 3;24(5).
- Cossu G, Tonlorenzi R, Brunelli S, Sampaolesi M, Messina G, Azzoni E, Benedetti S, Biressi S, Bonfanti C, Bragg L, Camps J, Cappellari O, Cassano M, Ciceri F, Coletta M, Covarello D, Crippa S, Cusella-De Angelis MG, De Angelis L, Dellavalle A, Diaz-Manera J, Galli D, Galli F, Gargioli C, Gerli MFM, Giacomazzi G, Galvez BG, Hoshiya H, Guttinger M, Innocenzi A, Minasi MG, Perani L, Previtali SC, Quattrocelli M, Ragazzi M, Roostalu U, Rossi G, Scardigli R, Sirabella D, Tedesco FS, Torrente Y, Ugarte G. Mesoangioblasts at 20: From the embryonic aorta to the patient bed. Front Genet 2022;13:1056114.
- Girolamo F, Errede M, Bizzoca A, Virgintino D, Ribatti D. Central Nervous System Pericytes Contribute to Health and Disease. Cells 2022 May 20;11(10).
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
